Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AKSYOTCMKTS:ECTEOTCMKTS:GADSOTCMKTS:IMRSQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKSYAksys$0.00$0.00▼$0.00N/AN/AN/AN/AECTEEcho Therapeutics$0.00$0.00$0.00▼$0.28N/AN/AN/AN/AGADSGadsden Properties$0.00$0.00$0.00▼$0.00N/A-7.548,596 shsN/AIMRSQIMRIS$0.00$0.00▼$0.00N/AN/A10 shsN/A10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKSYAksys0.00%0.00%0.00%0.00%0.00%ECTEEcho Therapeutics0.00%0.00%0.00%0.00%0.00%GADSGadsden Properties0.00%0.00%-66.67%+100.00%-50.00%IMRSQIMRIS0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKSYAksysN/AN/AN/AN/AN/AN/AN/AN/AECTEEcho TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AGADSGadsden PropertiesN/AN/AN/AN/AN/AN/AN/AN/AIMRSQIMRISN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKSYAksys 0.00N/AN/AN/AECTEEcho Therapeutics 0.00N/AN/AN/AGADSGadsden Properties 0.00N/AN/AN/AIMRSQIMRIS 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKSYAksysN/AN/AN/AN/AN/AN/AECTEEcho TherapeuticsN/AN/AN/AN/AN/AN/AGADSGadsden PropertiesN/AN/AN/AN/AN/AN/AIMRSQIMRISN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKSYAksysN/AN/A0.00N/AN/AN/AN/AN/AN/AECTEEcho TherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/AGADSGadsden PropertiesN/AN/A0.00∞N/AN/AN/AN/AN/AIMRSQIMRISN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKSYAksysN/AN/AN/AN/AN/AECTEEcho TherapeuticsN/AN/AN/AN/AN/AGADSGadsden PropertiesN/AN/AN/AN/AN/AIMRSQIMRISN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKSYAksysN/AECTEEcho TherapeuticsN/AGADSGadsden PropertiesN/AIMRSQIMRISN/AInsider OwnershipCompanyInsider OwnershipAKSYAksys3.80%ECTEEcho Therapeutics7.00%GADSGadsden Properties5.04%IMRSQIMRISN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKSYAksys87N/AN/ANot OptionableECTEEcho Therapeutics19N/AN/ANot OptionableGADSGadsden Properties2N/AN/ANot OptionableIMRSQIMRIS121N/AN/ANot OptionableIMRSQ, AKSY, ECTE, and GADS HeadlinesRecent News About These CompaniesTelecom Egypt signs agreement to speed up internet in Egypt, AfricaJanuary 19, 2024 | english.ahram.org.egInfant Health Among Puerto Ricans - Puerto Rico and U.S. Mainland, 1989-2000November 17, 2023 | medscape.comAll articles - FashionJune 10, 2023 | sofeminine.co.ukRising rates put pressure on U.S. insurers' reserves, Fitch saysMay 3, 2023 | ca.finance.yahoo.comThe Global Angio Suites Market is forecast to grow by $819.65 mn during 2022-2027, accelerating at a CAGR of 5.65% during the forecast periodApril 19, 2023 | finance.yahoo.comimrs-001February 18, 2023 | afro.comBoston Children’s Hospital Hale Family Building Opens the New IMRIS iMRI 3T-V Surgical TheatreSeptember 24, 2022 | wdtn.comTop HeadlinesView All Headlines3 Momentum Stocks That Could Soar Post-Market VolatilityBy Nathan Reiff | April 21, 2025View 3 Momentum Stocks That Could Soar Post-Market VolatilityNow Is the Time to Buy ServiceNow—The Rebound Is RealBy Thomas Hughes | April 24, 2025View Now Is the Time to Buy ServiceNow—The Rebound Is RealRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsBy Ryan Hasson | April 24, 2025View Rocket Lab Lands New Contract, Builds Momentum Ahead of EarningsO’Reilly Automotive: An Anytime Buy for Buy-and-Hold InvestorsBy Thomas Hughes | April 27, 2025View O’Reilly Automotive: An Anytime Buy for Buy-and-Hold InvestorsPepsiCo’s Stock Price is Disconnected From Reality: Time to BuyBy Thomas Hughes | April 28, 2025View PepsiCo’s Stock Price is Disconnected From Reality: Time to BuyIMRSQ, AKSY, ECTE, and GADS Company DescriptionsAksys OTCMKTS:AKSYAksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.Echo Therapeutics OTCMKTS:ECTE$0.0002 0.00 (0.00%) As of 09/7/2021Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.Gadsden Properties OTCMKTS:GADS$0.0002 0.00 (0.00%) As of 05/2/2025Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.IMRIS OTCMKTS:IMRSQIMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Monster Beverage Stock: Short Report Risks vs Upside Potential Onsemi Stock Confirms Bottom, But What’s the Upside? 3 Reasons Tesla Should Be a $300 Stock by June Amazon: Why The Great Comeback Rally Could Be About to Begin Is Reddit Stock a Buy, Sell, or Hold After Earnings Release? MarketBeat Week in Review – 04/28 - 05/02 ExxonMobil: Production Offset Prices, Capital Return Safe in 2025 Warning or Opportunity After Super Micro Computer's Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
